Increasing prevalence of HIV-1 subtype a in Greece: Estimating epidemic history and origin

Journal of Infectious Diseases

Volumn 196, Issue 8, 2007, Pages 1167-1176

  Paraskevis, Dimitrios ^a   Magiorkinis, Emmanouil ^a   Magiorkinis, Gkikas ^a   Sypsa, Vana ^a   Paparizos, Vassilios ^b   Lazanas, Marios ^c   Gargalianos, Panagiotis ^d   Antoniadou, Anastasia ^e   Panos, Georgios ^f   Chrysos, Georgios ⁱ   Sambatakou, Helen ^g   Karafoulidou, Anastasia ^h   Skoutelis, Athanasios ^j   Kordossis, Theodoros ⁱ   Koratzanis, Georgios ^k   Theodoridou, Maria ^l   Daikos, Georgios L ⁱ   Nikolopoulos, Georgios ^m   Pybus, Oliver G ⁿ   Hatzakis, Angelos ^a,o  

^a National Retrovirus Reference Center   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c Red Cross GH   (Greece)

^d GNA Gennimatas Hospital of Athens   (Greece)

^e Attiko University Hospital   (Greece)

^f 1st IKA Hospital   (Greece)

^g Hippokrateion GH   (Greece)

^h LAIKO GENERAL HOSPITAL   (Greece)

ⁱ Department of Pathophysiology ^*  (Greece)

^j Evangelismos GH   (Greece)

^k GH Sismanogleio   (Greece)

^l AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^m Hellenic Center for Disease Control and Prevention   (Greece)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o UNIVERSITY OF ATHENS   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; DNA SEQUENCE; FEMALE; GREECE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL;

ADULT; FEMALE; GREECE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PREVALENCE; VARIATION (GENETICS);

EID: 35348944475     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/521677     Document Type: Article

References (43)

1. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397:436-41.
2. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287:607-14.
3. Corbet S, Muller-Trutwin MC, Versmisse P, et al. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol 2000; 74:529-34.
4. Sharp PM, Bailes E, Gao F, Beer BE, Hirsch VM, Hahn BH. Origins and evolution of AIDS viruses: estimating the time-scale. Biochem Soc Trans 2000; 28:275-82.
5. Van Heuverswyn F, Li Y, Neel C, et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006; 444:164.
6. Simon F, Mauclere P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4:1032-7.
7. Yamaguchi J, McArthur CP, Vallari A, et al. HIV-1 group N: evidence of ongoing transmission in Cameroon. AIDS Res Hum Retroviruses 2006; 22:453-7.
8. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000; 288:55-6.
9. Melbye M, Biggar RJ, Ebbesen P, et al. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) 1984; 289:573-5.
10. Clumeck N, Sonnet J, Taelman H, Cran S, Henrivaux P. Acquired immune deficiency syndrome in Belgium and its relation to central Africa. Ann NY Acad Sci 1984; 437:264-9.
11. Gifford R, De Oliveira T, Rambaut A, et al. Increasing and unusual genetic diversity of HIV-1 in the UK [abstract 316]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Foundation for Retrovirology and Human Health, 2006.
12. Chaix ML, Descamps D, Harzic M, et al. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 2003; 17:2635-43.
13. Descamps D, Chaix ML, Andre P, et al. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr 2005; 38:545-52.
14. Deroo S, Robert I, Fontaine E, et al. HIV-1 subtypes in Luxembourg, 1983-2000. AIDS 2002; 16:2461-7.
15. Machuca R, Bogh M, Salminen M, et al. HIV-1 subtypes in Denmark. Scand J Infect Dis 2001; 33:697-701.
16. Sonnerborg A, Durdevic S, Giesecke J, Sallberg M. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997; 13:343-5.
17. Snoeck J, Van Laethem K, Hermans P, et al. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J Acquir Immune Defic Syndr 2004; 35:279-85.
18. Lospitao E, Alvarez A, Soriano V, Holguin A. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med 2005; 6:313-20.
19. Boni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 1999; 22:174-9.
20. Liitsola K, Holmstrom P, Laukkanen T, Brummer-Korvenkontio H, Leinikki P, Salminen MO. Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data. Scand J Infect Dis 2000; 32:475-80.
21. Op de Coul EL, Coutinho RA, van der Schoot A, et al. The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains. AIDS 2001; 15:2277-86.
22. Thomson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis 2001; 32:1732-7.
23. Nasioulas G, Paraskevis D, Paparizos V, Lazanas M, Karafoulidou A, Hatzakis A. Genotypic characterization of human immunodeficiency virus type 1 in Greece: multicentre study on HIV-1 heterogeneity. AIDS Res Hum Retroviruses 1998; 14:685-90.
24. Paraskevis D, Magiorkinis E, Katsoulidou A, et al. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Res 2005; 112:115-22.
25. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL
26. Swofford DL. PAUP*4.0: phylogenetic analysis using parsimony. Sunderland, MA: Sinaur Associates, 1998.
27. Schmidt HA, Strimmer K, Vingron M, von Haeseler A. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 2002; 18:502-4.
28. Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP. Bayesian inference of phylogeny and its impact on evolutionary biology. Science 2001; 294:2310-4.
29. Hue S, Pillay D, Clewley JP, Pybus OG. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci USA 2005; 102:4425-9.
30. Drummond AJ, Nicholls GK, Rodrigo AG, Solomon W. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 2002; 161:1307-20.
31. Drummond AJ, Rambaut A. BEAST v1.4. Available at: http://beast.bio.ed.ac. uk/. 2006.
32. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4:87-90.
33. Ciccozzi M, Gori C, Boros S, et al. Molecular diversity of HIV in Albania. J Infect Dis 2005; 192:475-9.
34. Apetrei C, Necula A, Holm-Hansen C, et al. HIV-1 diversity in Romania. AIDS 1998; 12:1079-85.
35. Bobkov AF, Kazennova EV, Selimova LM, et al. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J Med Virol 2004; 74:191-6.
36. Saad MD, Shcherbinskaya AM, Nadai Y, et al. Molecular epidemiology of HIV type 1 in Ukraine: birthplace of an epidemic. AIDS Res Hum Retroviruses 2006; 22:709-14.
37. Lazouskaya NV, Eremin VF, Adema KW, Gasich EL, Baan E, Lukashov VV. The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. AIDS Res Hum Retroviruses 2005; 21:830-3.
38. Zetterberg V, Ustina V, Liitsola K, et al. Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res Hum Retroviruses 2004; 20:1148-56.
39. Wensing AM, van de Vijver DA, Angarano G, et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis 2005; 192:958-66.
40. Arts J. Infection with subtype C HIV-1 of lower replicative fitness as compared to subtypes A and D leads to slower disease progression in Zimbabwean and Ugandan women [abstract TUAA0204]. In: Program and abstracts of the XVI International AIDS Conference (Toronto). Canadian Association for HIV Research, 2006.
41. Kantor R, Katzenstein DA, Efron B, et al. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med 2005; 2:e112.
42. Chaix ML, Rouet F, Kouakoussui KA, et al. Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Cote d'Ivoire. Pediatr Infect Dis J 2005; 24:1072-6.
43. Doualla-Bell F, Avalos A, Brenner B, et al. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob Agents Chemother 2006; 50:4182-5.